SLEEVE GASTRECTOMY IN PATIENTS WITH MORBID OBESITY: IMPACT ON LIPID PROFILE

Authors

  • I. M. Todurov Center for Innovative Medical Technologies of NAS of Ukraine, Kyiv, Ukraine
  • O. V. Perekhrestenko Center for Innovative Medical Technologies of NAS of Ukraine, Kyiv, Ukraine
  • O. O. Kalashnikov Center for Innovative Medical Technologies of NAS of Ukraine, Kyiv, Ukraine
  • S. V. Kosiuchno Center for Innovative Medical Technologies of NAS of Ukraine, Kyiv, Ukraine
  • O. I. Plehutsa Center for Innovative Medical Technologies of NAS of Ukraine, Kyiv, Ukraine
  • V. M. Yakimets Center for Innovative Medical Technologies of NAS of Ukraine, Kyiv, Ukraine

DOI:

https://doi.org/10.11603/1681-2786.2019.2.10482

Keywords:

morbid obesity, dyslipidemia, sleeve gastrectomy, results

Abstract

Purpose: to investigate the effect of sleeve gastrectomy on lipid profile in morbidly obese patients with preoperative dyslipidemia.

Materials and Methods. The basis of the study was the materials of clinical examination and surgical treatment of 105 morbidly obese patients (47 men and 58 women, mean age (41.8±12.4) years who underwent sleeve gastrectomy.

Results. Dyslipidemia was diagnosed preoperatively in 86 (81.9 %) patients. Regular use of lipid-lowering drugs in 44 (51.1 %) patients before surgery did not lead to normalization or significant improvement of lipidogram parameters. The procedure led to decrease in the mean total cholesterol level from (5.73±1.0) to (4.92±0.5) mmol/l, triglycerides from (1.91±0.9) to (1.43±0.3) mmol/l, regression coefficient of atherogenicity from (3.84±0.8) to (2.9±0.6) in 60 months after surgery (P < 0.05). In 60 months after a gastric resection of the stomach, dyslipidemia (in all type 2a) was diagnosed in 15 (62.5 %) patients of the main group with preoperative lipid metabolism, in 9 (37.5 %) patients the lipidogram parameters were normalized in patients with morbid obesity, which indicates the effectiveness of the surgery.

Conclusions. Sleeve gastrectomy is effective method for correction of dyslipidemia in morbidly obese patients. The implementation of this intervention results in a significant and persistent (5-year postoperative observation) reduction in the average level of total cholesterol, triglycerides and atherogenic factor.

Author Biographies

I. M. Todurov, Center for Innovative Medical Technologies of NAS of Ukraine, Kyiv, Ukraine

Doctor of Medical Sciences, Professor, Director of the National Center for Innovative Medical Technologies of NAS of Ukraine, Director Department of Endocrine and Metabolic Surgery, laureate of the State Prize of Ukraine

O. V. Perekhrestenko, Center for Innovative Medical Technologies of NAS of Ukraine, Kyiv, Ukraine

Candidate of Medical Sciences, Deputy Director for Scientific Work of DNU “Center for Innovative Medical Technologies of NAS of Ukraine”, Leading Researcher of Endocrine and Metabolic Surgery Department

O. O. Kalashnikov, Center for Innovative Medical Technologies of NAS of Ukraine, Kyiv, Ukraine

Candidate of Medical Sciences, Leading Researcher at the Center for Innovative Medical Technologies of NAS of Ukraine

S. V. Kosiuchno, Center for Innovative Medical Technologies of NAS of Ukraine, Kyiv, Ukraine

Candidate of Medical Sciences, Head of the Department of Minimally Invasive Surgery, DNU "Center for Innovative Medical Technologies of NAS of Ukraine"

O. I. Plehutsa, Center for Innovative Medical Technologies of NAS of Ukraine, Kyiv, Ukraine

Candidate of Medical Sciences, Senior Researcher at the Center for Innovative Medical Technologies of NAS of Ukraine, Endocrine and Metabolic Surgery Department

V. M. Yakimets, Center for Innovative Medical Technologies of NAS of Ukraine, Kyiv, Ukraine

Doctor of Medical Sciences, Professor, Deputy Director for Scientific-Organizational and Methodological Work of DNU “Center for Innovative Medical Technologies of NAS of Ukraine”, Honored Doctor of Ukraine

References

Agrawal, S. (2016). Obesity, bariatric and metabolic surgery. A practical guide. Spring. DOI: https://doi.org/10.1007/978-3-319-04343-2

Angrisani, L., Santonicola, A., Iovino, P., Vitiello, A., Higa, K., Himpens, J., Buchwald, H., & Scopinaro, N. (2018). IFSO Worldwide Survey 2016. Primary, Endoluminal, and Revisional Procedures. Obesity Surgery. Retrieved from: https://doi.org/10.1007/s11695-018-3450-2 DOI: https://doi.org/10.1007/s11695-018-3450-2

Karcz, W.K., & Thomusch, O. (2012). Principles of metabolic surgery. Springer. DOI: https://doi.org/10.1007/978-3-642-02411-5

Kaur, J.A. (2014). Comprehensive review on metabolic syndrome. Cardiol. Res. Pract., 1-21. DOI: https://doi.org/10.1155/2014/943162

O’Neill, S., & O’Driscoll, L. (2015). Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes. Rev., 16 (1), 1-12. DOI: https://doi.org/10.1111/obr.12229

Neaton, J.D., Blackburn, H., Jacobs, D., Kuller, L., Lee, D.J., Sherwin, R., Shih, J., Stamler, J., & Wentworth, D. (1992). Serum cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial. Multiple Risk Factor Intervention Trial Research Group. Arch. Intern. Med., 152, 1490-500. DOI: https://doi.org/10.1001/archinte.1992.00400190110021

https://www.who.int/ru/news-room/fact-sheets/detail/the-top-10-causes-of-death

Published

2019-10-18

How to Cite

Todurov, I. M., Perekhrestenko, O. V., Kalashnikov, O. O., Kosiuchno, S. V., Plehutsa, O. I., & Yakimets, V. M. (2019). SLEEVE GASTRECTOMY IN PATIENTS WITH MORBID OBESITY: IMPACT ON LIPID PROFILE. Bulletin of Social Hygiene and Health Protection Organization of Ukraine, (2), 64–68. https://doi.org/10.11603/1681-2786.2019.2.10482

Issue

Section

The science for health care practice